Synairgen plc (LON:SNG – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 5.42 ($0.07) and traded as high as GBX 5.44 ($0.07). Synairgen shares last traded at GBX 5.25 ($0.07), with a volume of 310,086 shares.
Synairgen Trading Down 3.2 %
The business’s 50 day moving average price is GBX 5.42 and its 200-day moving average price is GBX 6.59. The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The company has a market cap of £10.22 million, a price-to-earnings ratio of -104.90 and a beta of -2.23.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Featured Stories
- Five stocks we like better than Synairgen
- What Is WallStreetBets and What Stocks Are They Targeting?
- Growing Twice as Fast as Tesla, XPeng is a Buy
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 4 Stocks Building Long-Term Value for Shareholders
- Comparing and Trading High PE Ratio Stocks
- FedEx Stock Has Analysts Upgrading in Bulk, a Sudden Discount
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.